Visual identity and branding motivation for healthcare and eyecare startups with a twist for artificial intelligence
download: https://www.dropbox.com/s/x7d3et04639jx0u/healthcare_visualBranding.pdf?dl=0
Computational Disease Management with Wearable DevicesPetteriTeikariPhD
Machine Learning modelling of disease trajectory with deep
learning and/or Gaussian Processes.
Alternative download link:
https://www.dropbox.com/s/jg73ymvkenx8rv4/computational_disease_management.pdf?dl=0
Notes on "Artificial Intelligence in Bioscience Symposium 2017"PetteriTeikariPhD
Including talks for drug discovery, drug target selection, scientific reproducibility, machine learning in omics and GWAS, network biology, functional connectome, endotype discovery, bayesian causal networks, systems biology, brain decoding, place cells, personalized medicine, sepsis warning system, knowledge engineering, CRISPR genome editing, data science stacks, feline gene sequencing, generative models for chemical compounds via variational autoencoders, ethics in AI medicine
https://www.bioscience.ai/ | #bioai2017 | Sept 14, 2017 | The British Library, London
Alternative download for slides if Slideshare download is acting up: https://www.dropbox.com/s/2wdfuqzifns7475/bioai2017.pdf?dl=0
Data-driven models for efficient diagnosis and disease management. From Academia to Startups.
Talk given at Crabb Lab Meeting, City University, London UK – Wed 23 August 2017
Visual identity and branding motivation for healthcare and eyecare startups with a twist for artificial intelligence
download: https://www.dropbox.com/s/x7d3et04639jx0u/healthcare_visualBranding.pdf?dl=0
Computational Disease Management with Wearable DevicesPetteriTeikariPhD
Machine Learning modelling of disease trajectory with deep
learning and/or Gaussian Processes.
Alternative download link:
https://www.dropbox.com/s/jg73ymvkenx8rv4/computational_disease_management.pdf?dl=0
Notes on "Artificial Intelligence in Bioscience Symposium 2017"PetteriTeikariPhD
Including talks for drug discovery, drug target selection, scientific reproducibility, machine learning in omics and GWAS, network biology, functional connectome, endotype discovery, bayesian causal networks, systems biology, brain decoding, place cells, personalized medicine, sepsis warning system, knowledge engineering, CRISPR genome editing, data science stacks, feline gene sequencing, generative models for chemical compounds via variational autoencoders, ethics in AI medicine
https://www.bioscience.ai/ | #bioai2017 | Sept 14, 2017 | The British Library, London
Alternative download for slides if Slideshare download is acting up: https://www.dropbox.com/s/2wdfuqzifns7475/bioai2017.pdf?dl=0
Data-driven models for efficient diagnosis and disease management. From Academia to Startups.
Talk given at Crabb Lab Meeting, City University, London UK – Wed 23 August 2017
Working better together: community health and primary careNHS Confederation
This slide pack captures the main points from a workshop on integrated working between primary care and community health services. The workshop was organised by the NHS Confederation Community Health Services Forum in partnership with the National Association of Primary Care, in September 2014
Marketing proposal to Hartford HealthcareArchit Patel
The presentation is a brief description to the proposed marketing strategy for the Hartford healthcare specifically targeting on the New Health Enhancement Program proposed for Connecticut state employees.
Open space technology is a perfect fit for healthcare! In an era where we know front line staff, clinicians and patients are at the heart of healthcare reform; open space technology is a breath of fresh air. Here are a few things we learned along the way.
Advancing Healthcare Technology with Open Source SoftwareAchieve Internet
The focus, and heated debate, on the Affordable Care Act (ACA) is causing major change in the healthcare industry. The ACA seeks to provide more affordable care and mandates the use of cutting edge technology solutions to provide inter-operability and patient engagement in order to accomplish the desired goals.
Drupal has the power and capabilities to help meet these goals, and is already Drupal is being used by a number of major Healthcare related companies from Florida Hospitals, WellPoint, Dexcom, and Alliance Imaging. Drupal has the ability to achieve and comply with the desired outcomes of the ACA, from patient engagement, physician satisfaction and inter-operability between EMR systems.
In this webinar, Achieve Internet will review how Drupal and Open Source technology solutions can greatly improve Healthcare (including patient outcomes, better patient experiences, and increased usability) by enhancing, extending and ultimately replacing the current Healthcare technology on the market.
Analyzing Patient Scheduling, No Shows, and Cancellations in a Specialty- Car...Pranjal Singh
In this talk, I present a large-scale data analysis that I have undertaken to better define scheduling and patient behavior with respect to no-shows, cancellation, and access to timely care in a specialty clinic
Salesforce Health Cloud and Partners: Improving the Care ExperienceDreamforce
Salesforce and the hundreds of health partners in our ecosystem are creating solutions that extend Health Cloud to drive a better overall patient experience.
See how some of these partners, who offer solutions ranging from payments to scheduling to care management, make an effort to help providers better manage patients’ care journeys. In the coming months, these apps will be available on the Salesforce AppExchange, the world’s largest and longest-running enterprise apps marketplace.
Big Data [sorry] & Data Science: What Does a Data Scientist Do?Data Science London
What 'kind of things' does a data scientist do? What are the foundations and principles of data science? What is a Data Product? What does the data science process looks like? Learning from data: Data Modeling or Algorithmic Modeling? - talk by Carlos Somohano @ds_ldn at The Cloud and Big Data: HDInsight on Azure London 25/01/13
The 10 Most Influential Leaders in MedTech Companies 2020 September 2020Merry D'souza
The 10 most influential leaders in medtech companies 2020 september 2020; Insights Succcess has published Magazine on 10 Most Influential Leaders in MedTech Companies in the September 2020.
Diagnos is a publicly traded Canadian corporation with a mission of early detection of critical health issues through the use of its artificial intelligence tool, CARA (computer-assisted retina analysis). CARA is accessible securely over the Internet, is compatible with all recognized image formats and brands of fundus cameras, and is EMR (electronic medical record) compatible. CARA is a cost-effective tool for screening large numbers of patients in real time and has been cleared for commercialization by several regulatory authorities such as Health Canada, the U.S. Food and Drug Administration, and the European Union.
Wearables iot development for patient engagementLucas Holt
Unmet Wearable Needs & Innovation for Health.
Role of technology, cost, and adherence in developing - mHealth, sensors, and apps to improve patient care, health, and engagement. Establishing Value-Based Collaborations that work.
Working better together: community health and primary careNHS Confederation
This slide pack captures the main points from a workshop on integrated working between primary care and community health services. The workshop was organised by the NHS Confederation Community Health Services Forum in partnership with the National Association of Primary Care, in September 2014
Marketing proposal to Hartford HealthcareArchit Patel
The presentation is a brief description to the proposed marketing strategy for the Hartford healthcare specifically targeting on the New Health Enhancement Program proposed for Connecticut state employees.
Open space technology is a perfect fit for healthcare! In an era where we know front line staff, clinicians and patients are at the heart of healthcare reform; open space technology is a breath of fresh air. Here are a few things we learned along the way.
Advancing Healthcare Technology with Open Source SoftwareAchieve Internet
The focus, and heated debate, on the Affordable Care Act (ACA) is causing major change in the healthcare industry. The ACA seeks to provide more affordable care and mandates the use of cutting edge technology solutions to provide inter-operability and patient engagement in order to accomplish the desired goals.
Drupal has the power and capabilities to help meet these goals, and is already Drupal is being used by a number of major Healthcare related companies from Florida Hospitals, WellPoint, Dexcom, and Alliance Imaging. Drupal has the ability to achieve and comply with the desired outcomes of the ACA, from patient engagement, physician satisfaction and inter-operability between EMR systems.
In this webinar, Achieve Internet will review how Drupal and Open Source technology solutions can greatly improve Healthcare (including patient outcomes, better patient experiences, and increased usability) by enhancing, extending and ultimately replacing the current Healthcare technology on the market.
Analyzing Patient Scheduling, No Shows, and Cancellations in a Specialty- Car...Pranjal Singh
In this talk, I present a large-scale data analysis that I have undertaken to better define scheduling and patient behavior with respect to no-shows, cancellation, and access to timely care in a specialty clinic
Salesforce Health Cloud and Partners: Improving the Care ExperienceDreamforce
Salesforce and the hundreds of health partners in our ecosystem are creating solutions that extend Health Cloud to drive a better overall patient experience.
See how some of these partners, who offer solutions ranging from payments to scheduling to care management, make an effort to help providers better manage patients’ care journeys. In the coming months, these apps will be available on the Salesforce AppExchange, the world’s largest and longest-running enterprise apps marketplace.
Big Data [sorry] & Data Science: What Does a Data Scientist Do?Data Science London
What 'kind of things' does a data scientist do? What are the foundations and principles of data science? What is a Data Product? What does the data science process looks like? Learning from data: Data Modeling or Algorithmic Modeling? - talk by Carlos Somohano @ds_ldn at The Cloud and Big Data: HDInsight on Azure London 25/01/13
The 10 Most Influential Leaders in MedTech Companies 2020 September 2020Merry D'souza
The 10 most influential leaders in medtech companies 2020 september 2020; Insights Succcess has published Magazine on 10 Most Influential Leaders in MedTech Companies in the September 2020.
Diagnos is a publicly traded Canadian corporation with a mission of early detection of critical health issues through the use of its artificial intelligence tool, CARA (computer-assisted retina analysis). CARA is accessible securely over the Internet, is compatible with all recognized image formats and brands of fundus cameras, and is EMR (electronic medical record) compatible. CARA is a cost-effective tool for screening large numbers of patients in real time and has been cleared for commercialization by several regulatory authorities such as Health Canada, the U.S. Food and Drug Administration, and the European Union.
Wearables iot development for patient engagementLucas Holt
Unmet Wearable Needs & Innovation for Health.
Role of technology, cost, and adherence in developing - mHealth, sensors, and apps to improve patient care, health, and engagement. Establishing Value-Based Collaborations that work.
Putting Pandora back in the box using Emerging Technologies to Fight PandemicsKarthiga Ratnam
A global panel of pundits discussed how can emerging technologies like AI, Big Data, Robotics, IoT, and Biotechnology help us fight today’s and tomorrow’s pandemics. Our panelists will include a cross-section of experts and practitioners across multiple disciplines. During our one-hour discussion, we explored what the pundits have to say about combating this pandemic. What tools and technologies are currently at their disposal? What new solutions do they believe need to be developed? Can human ingenuity and innovation help us put pandora back in the box?
SUPERMATH’s Ultimate Geek Fest Analytics conference/expo features brainy solu...conferencc
A new business intelligence conference envisions us in a smarter world driven by predictive analytics. More than 20 companies will showcase business intelligence solutions in a variety of fields including bioinformatics and predictive analytics.
ACS EMERGING & DEEP TECH WEBINAR: THE RISE OF AI AND DATA SCIENCE AND ITS IMP...Kelvin Ross
In recent years Big Data, Data Science and AI has accelerated to point where technological systems are becoming more pervasive in our everyday lives. All aspects of society, work and industry are transforming in this 4th Industrial Revolution. Our personal data is now used to control our searches, news feeds and viewing recommendations. AI in healthcare is diagnosing disease, and proposing medical interventions. Facial recognition is granting us access, and monitoring our safety. Chat bots and automated agents are automatically handling our requests and vetting our applications.
With the increasing power of data and analytics comes responsibility. Our tech titans have gathered enormous power through collection of our personalised data. Recent failures have also highlighted how self-regulation has failed our data can be used weaponised against us, such as reflecting inherent racial biases or manipulating election outcomes. Community expectation is for government to regulate, and put in place appropriate governance and oversight structures.
In this talk Kelvin will explore the technological paradigm shift of AI and data science, review emerging ethical issues, and discuss regulatory and governance trends.
Most Influential Robotics Trailblazers, Making Wave in The Industry - 2024.pdfInsightsSuccess4
Dr. Haibin Zhu, Vice President – Systems Science and Engineering, IEEE SMC Society and Professor, Nipissing University, Canada, is a trailblazer in the field of computer science and robotics. His academic journey began with a bachelor’s degree in computer engineering in the early 1980s.
7 Reasons why Companies & Government should invest in Digital TransformationIsmail Sayeed
Early adoption of digital solutions to provide services, whether health related or not, allows organisations to be ready for future user demands. The large pool of data on patterns of service/product consumption, feedback and possible future behaviour (extracted from data analytics) can guide strategic decisions on what to invest in and for whom.
Digital healthcare innovation was needed decades ago, with or without a global health emergency. Other industries with complex systems have rapidly adopted digital transformation; such as logistics networks, taxation, commerce and others
- except healthcare.
A company that is already accustomed to some form of digital-based communication and operations (as much as possible) are the ones most able to survive and thrive in these circumstances.
A government body that can still function and serve remotely and digitally is the most ideal form of democracy. An organisation with remote workers, paperless reporting, established telecommunications through all chains of command are really agile in its truest form.
I had predicted 2 years ago that digital healthcare solutions would be the dominant narrative for the emerging middle class of many developing countries in Asia.
it is time for the global industry to transform itself to the new reality.
Now.
Catalog of Companies_mHealth Israel at AdvaMED 2019Levi Shapiro
Description of Israeli medtech, digital health and connected health startups exhibiting at AdvaMED, the MedTech Conference, 2019. Includes XR Health, Theranica, Oxitone, Bio-T, Fitango, RMDY, RSIP Vision, Gals Bio, Senso Medical, Belkin Laser, MobileODT, Sonivie
Energy storage innovation, both at micro and grid scale, is at the cusp of several major breakthroughs which are already impacting consumer electronics and autonomous transportation and several other consumer and industrial uses. Battery prices have come down significantly. Product options are available. With that comes commercial opportunities, policy challenges, industry disruption, new business models, and an array of new startups. What are some emerging energy storage technologies? Who are the players? What adjacent technologies are moving pieces in this game (IoT, cloud, EVs, utilities, distributed generation, transportation networks, mobility tech, sensors etc.). What will this world look like for industry, startups, governments, and consumers? How can existing infrastructure evolve to enable making the most of such breakthroughs? What are the regulatory obstacles in the five key markets where energy storage might emerge first (EU, Australia, Latin-America, South Africa, and USA)?
Building Trust in a Tense Information Society, Daniel Weitzner, Director, MIT...MIT Startup Exchange
Building Trust in a Tense Information Society, Daniel Weitzner, Director, MIT CSAIL Decentralized Information Group. Keynote held at MIT Startup Exchange (STEX) Cybersecurity Innovation workshop (5/28) at MIT on Thursday May 28, 2015, 8:30 AM to 11:30 AM, at One Main Street, Cambridge, MA, USA.
Cybersecurity investment trends, Chris Lynch, Partner, Atlas Ventures. MIT Startup Exchange
"Cybersecurity investment trends" Chris Lynch, Partner, Atlas Ventures. Cybersecurity Innovation (5/28), MIT Startup Exchange (STEX), Thursday May 28, 2015, 8:30 AM to 11:30 AM, at One Main Street, Cambridge, MA.
Welcome: "MIT's Cybersecurity startups," Trond Undheim, Ph.D., Lead, MIT Startup Exchange, MIT ILP (host), CYBERSECURITY INNOVATION (5/28), MIT STEX cluster workshop, Thursday May 28, 2015, 8:30 AM to 11:30 AM, ,One Main Street, Cambridge, MA.
"MIT's Food Tech Startups," Trond Undheim, Ph.D., Lead, MIT Startup Exchange, MIT ILP (host). Presented at MIT Startup Exchange (STEX), cluster workshop on Food Tech Innovation, 22 April, 2015, MIT.
"The Future of Food," Manoj Fenelon, Director of Foresight, PepsiCo. MIT Startup Exchange
"The Future of Food," Manoj Fenelon, Director of Foresight, PepsiCo. Presented at MIT Startup Exchange (STEX) cluster workshop on Food Tech Innovation, 22 April, 2015.
Food, Sensors, Startups - The Road Ahead From a MIT perspectiveMIT Startup Exchange
"Food, sensors, startups - the road ahead from an MIT perspective," Timothy M. Swager, John D. MacArthur Professor of Chemistry at MIT and Faculty Director of the Deshpande Center for Technological Innovation. Presented at the MIT Startup Exchange (STEX) cluster workshop on Food Tech Innovation, 22 April 2015, MIT. Twitter: #STEXfood.
Future opportunities for food tech product innovation from a research perspec...MIT Startup Exchange
"Future opportunities for food tech product innovation from a research perspective," Omer Yilmaz, Ph.D., Assistant Professor of Biology, MIT and gastrointestinal pathologist, Massachusetts General Hospital and Harvard Medical School. Presented at MIT Startup Exchange (STEX) cluster workshop on Food Tech Innovation, 22 April 2015, MIT. Twitter" #STEXfood
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Healthy Aging - Technology Solutions and Innovation from MIT-Connected Startups June 4, 2015
1. HealthyAging- Technology SolutionsandInnovation fromMIT-Connected Startups
cUfticQlbox
AtlasSD - helps older adults continue living independent and
lb>N«JU fulfilling livesinthehomestheylove,whilerespectingtheirprivacy
and dignity. The Atlas5D tablet is a smart sensor that helps families
stay^in sync bysharing changes in howandwhena person is moving in their home and
sendingautomatictextore-mailalertsifthereisa changeinnormalactivity.
ZebKimmel, M.D.,CEO(zeb@atlas5d. com),JonVarsamkPh.D.,CTO
(Jon@atlas5d. com)
http://www.atlas5d.com
ClinicalBox, Inc. - softwaresolutionsto ensuresmooth coordinationand
patient engagement acrossthe carecontinuum thrdvgh a software platform
thatengagesproviders, patientsandtheirfamilies. Ourmaintarget:high
volume surgical procedures affecting an aging population. ClinicalBox
followsthepatientacrossallthestagesofsurgery(pre-op,intra-op,post-op,
post-discharge), targeting reduced delays/cancellations, reduced readmissions, increased
patient satisfaction and improved outcomes. We are able to integrate with all major
electronichealthrecordsystems.
FarbodHagigiPh.D.,MPH,Founder& CEO
(farbod. hagigi@clinicalbox. com) 617-394-8644
http://www. clinicalbox. com
PathMaker Neurosystems, Inc. - is developing non-
invasive neuromodulation products based on trans-NEUROSYSTEMS INC.
gp^^ direct- current~stimu'iatioa"" tsDCS ^ au^ew
modality that amplifies signals goingfrom the brain to distal muscles byapplying external
currenttospecificpointsalongthespine. Wehavea breakthroughtreatmentforreversing
paralysis,muscleweaknessandmuscletonedisordersinpatientswithstroke,cerebralpalsy,
spinalcordinjury,TBIandevenoldage.
NaderYaghoubi, M. D., Ph.D., CEO (nyaghoubi@pmneuro. com) 617-968-3006
http://pmneuro. com/
General Fluidics Corp - is an in-vitro diagnostic and healthcare
FM^cs mformation technology company. Our mission is to make high quality
Corporation diagnostic information more useful and accessible anywhere. Utilizing
innovative microfluidic technology, our point-of-care blood diagnostic
platform delivers central lab quality routine bloo4 testing when andwhere
it is most useful to the patient and doctor with 1/lOth ofthe blood required for centralized
testing.
Ramin Haghgooie, Ph.D.,VicePresident ofEngineering
(ramin.haghgooie@gmail.com) 617-869-4499
// nit. ed
2. XlB
XMicrobial - provides anti-microbial technology platform to be
ICROBIAL incorporated in theexisting microbe-deactivation products.
ShirleyYoung,Technology Development & Testing, Co-founder
(shirley@xmicrobial. com)
Dr. RogerNassar,Technology Development, CTO, Co-founder
(roger(@xmicrobial.com)
http://www. XMicrobial. com
,
S HoowakiLLC- engineersmicro andnanosurfacesto solve friction
andsurfacetensionproblems.Weprovidesolutionsbymanufacturmg
the surfaces on tooling so that mass volumes of improved products can be made at
competitive costs. Solutions include: anti-migration surfaces forstents; highgripsurfaces for
robotic sewing; low friction vascular catheter liners; surfaces to manipulate blood; super
hydrophobic surfaces for accurate dosing.
Ralph Hulseman, M.S.ChE., President (ralphhulseman@hoowaki. com) 864-238-5631
http://www.hoowaki.com
Bionolux,LLC- Bionoluxisa newkindofwearablescompany. Weare
<?/, 'i^ approaching fitness from a different direction. We seek ways to build
^Ss^ wearable,senseable, and perhaps someday even invisible technologies
that service our social and emotional lives. The company is currently
developing the BE Sensor, a ring that measures electrodermal response
and transforms it into a compelling display for use by consumers to feedback and share the
intensity oftheir ownresponses. Ultimately, weintendto enterthemedicaldevicemarket
with a more robust and mental health-focused version for diagnosis and treatment of
disorderswith electrodermal biomarkers.
Jocelyn Scheirer, CEO, Founder (jscheir@alum. mit. edu) 617-515-6921
http://blonolux. com
^ Experfy - is a big data consulting marketplace where enterprises hire
vetted experts and vendors for their data, analytics and business
intelligence projects. Offeringcutdng-edge health analytics expertise.
Harpreet Singh, Ph.D.,Co--Founder & Co-CEO (hsingh@experfy. com) 844-397-3739
https://www.experfy.com
THOR Tourniquet - TheTHORtourniquet stands for the Traumatic
Hemorrhage One-hand Response tourniquet. It is intended asa life-
a6 SR'N'TQ ^E*r| saving device, designed for intuitive, simple and rapid deployment m
high-stress scenarios where excessive extremity hemorrhage needs to be
stemmedquicklyandeffectively.
Anton Hunt, Co-founder, Student- Dept. ofMechanical Engineering MIT
(antonh@mit.edu) 857-600-7943
NickDemas,Co-founder(demas@mit.edu)
http://www. thortourniquet. com
Trond Undheim, Ph.D.
http://startupexchange. mit.edu
3. Participating Startup Company Attendee's Biographies
AtlasSD - http://www.atlas5d.com
Zeb Kimmel, M. D., CEO - zeb@atlas5d. com
Zebhastwodecades ofexperience in medicine andcomputer science. Hemostrecently spentfiveyears inMcKinsey's
Healthcare Technology Practice, _servmg governments, hospitals, pharmaceutical firms, andmedical device mamiifacturers
worldwide Priorto McKinsey,Zebwasa pqstdoctoralfellowatHarvardMedicalSchool,andanearlymemberofthe
federal Office of the National Coordinator for Health Information Technology. Zeb has an M.D. from Northwestern
University; an MBAfrom MIT Sloan, anM.S.in computer sciencefrom the University ofIllinois atUrbana-Champaign,
anda BA in math-physics from Brown University.
Jon Varsanik Ph. D., CTO - jon@adas5d. com
Jon is an expert in image processing, data analytics, and algorithm development. Before Atlas5D, he was a technical
constdtmt with Exponent, where heworkedwith some ofthe Fargestandmost innovative compames intheworld. Hehas
solvedproblemsrangingfromdevelopmentofconsumerelectronicsproductstocreatingnovelthreatdetectionalgorithms
to root cause analysis ofindustnal fires. Previously, Jonworked at Draper Laboratoryis a Draper Fellow, and-his-thesis
work was partially funded by DAEPA. His scientific publications and patents include advances in nanofluidics, team
dynamics,andimageprocessing.JonhasfourdegreesfromMIT:twoBachelor'sdegrees,oneMastersofengineering,and
the Ph.D. in electrical engineering andcomputer-science.
ClinicalBox, Inc.- http://www.dinicalbox.com
Farbod Hagigi Ph.D., MPH,Founder & CEO - farbod. hagigi@clmicalbox. com 617-394-8644
Dr.Ha^igihaslivedandbreathedcoordination,patient-engagementandvalue-basedhealthcareforthepastthirteenyears.
He bnnes hissignificant experience across the healtlicare industry to ClinicalBox's software solutions. Prior to
ClinicalBox he was management consultant at The Boston Consulting Groupwhere he collaboratedI withC-suite
executives on significant strategic andoperational challenges iacingtheir businesses.
PathMakerNeurosystems,Inc.- http://pmneuro.com/
Nader Yaghoubi, M.D., Ph.D., CEO - nyaghoubi@pmneuro. com 617-968-3006
Dr. Yaghoubi hascnw 15years of_experience in the creation, operations andfinancing oflife science companies. Before
hisinvolvementwithPathMakerNeurosystems,heestablished,asPresidentandFoundingCEO,SymbiotixBiotherapies,
a biotechnology company, developing novel molecular therapeutics based on the human microbiome. Dr. Yaghoubi
receivedanM.D.andPh.D.inMolecularPharmacolo^yfromthecombineddegreeprogramatBostonUniversity.School
ofMedicine.HisdoctorateworkonthedevelopmentofKigh-throughputautomatedelfictrophysiologicals^temsresultedhi
five issued patents, received one ofthe University's highest awards for dissertational research, and was the basis of a
venture-backedbiotechnologycompanyfocusedonaeuroscience.
General Fluidics Corp
Ramin Haghgooie, Ph.D., VicePreBidentofEngineering -rajnm. haghgooie@gmail. com 617-869-4499
Received hisB.S.E., m Chemical Engineeringfrom the University of Michigan and his M.S., Ph.D., Chemical
Engineering from MIT.
XM.icrobial - http://www.XMicrobial.com
ShirleyYoung,TechnologyDevelopment& Testing,Co-founder- shirley@xmicrobial.com
ShirieygraduatedfromMassachusettsInstituteofTechnologywithBachelor'Degreesin ChemicalEngineeringand
Electrical Engineering Shirley also earned a masterdegreeTin electrical engineering. In addition toi XMicrobTal, Shirley is
thefounder ofGlobalAdvanced Technology, Inc. (GATf), GATIT, SafvE, a 501(c)(3)"non-profit organization and"
InvestmentConsulting.GATITwasacquiredin 2001.
Dr. Roger Nassar, Technology Development, CTO, Co-founder - roger(@xmicrobial. com
Roger^ graduated^fonn the Universityof Leicester,UK, with a PhJXin chemistrym2001. His researchtrainingin
ChemistryandBiotechnologywasatClemsonandNotreDameUniversitiesandMIT. Rogerhasappliedhisscientific
skills to the discovery and development of novel photo-lithographic materials, optimization andscale-upoffluoro-
surfactantproductionandsurfacemodificationsformicrofluidicdevices,andtotheconceptionofnoveltechniquesinfluid
dismfection and rapid point-of-use microbe detection. These diverse assets in chemistry and its applications combined
with product development and customer support have been instrumental to the success of Roger as a scientist and an
entrepreneur.
''*B''''""T°il» /f.!<S:''fVWp 3VV.i&V/S^""-'S'r
[ib.«'<-9o^/'%i!,S!i.; si'yi^'IS^.^ii li'sS.;.
^ .^^l 7F<^/ ..r^^' r l'
;) : j^'Sni ;'S^a^<», ..
4. Hoowaki LLC - http://www. hoowaki. com
RalphHulseman,M.S.ChE., President- ralphhulseman@hoqwalu.com)864^38^5631
Ralph received his' B.S. and M.S. in Chemicaf Engineering 1980, 1981 at MIT. He worked 1 year for MIT as Assistant
DirectorofChemicalEngineeringPracticeSchool.
Bionolux LLC - http://bionolux. com
Jocelyn Scheirer, CEO, Founder - jscheir@alum. mit.edu 617-515-6921
Jocelyn began her initial explorations in the industry while a Ph.D. student at MIT Media Lab's Affectiye Computing
Group. There, shedeveloped herfirst wearables, interactive objects and digital artexhibitions. WorkingattheMedia Lab,
Jocelyn wasableto blend her understanding ofscientific practice andmethodology with herpassion andexperience asan
abstractandconceptualartist,thusbridgingthegapbetweenhardwareandIaesthetics.In2006,shefoundedEmpathyx, a
company focused on intercommunication equipment and systems. In 2009 she helped found and served as Director of
Operationsfor Affectiva, a companydedicatedto digitizingemotionwith the largest databaseoffacial expressionsever
llected, and an initial biosensor product called the Q Sensor. Jocelyn has authored and co-authored numerous articles
andpapers onaffective computing andsensingtechnology, andpresented atnational industry-related conferences. Shehas
served asa research analyst at Harvard University andasa consultant to different departments atMIT.
Experfy - https://www. experfy. com
Harpreet Singh, Ph.D., Co-Founder & Co-CEO - hsingh@experfy. com VAA-Wl-Siyd
Harpreet Singh is responsible for Experfy's strategy andoperations. He is an entrepreneur with experience leadingcross-
functionalteamsinglobalexecutionofproductdevelopment,businessstrategy,operations,andtechnologyfunctions.With
exceptional emphasis on structured governances, he managed the program management initiatives for sixty technology
startups from Citigroup's e-Citi Venture Portfolio .Office. In a later role as Director ofTechnology, also at Citigroup, he
architected the infrastructure ofglobal multi-tiered, web-basedelectronic exchanges. Harpreet subsequently established the
Project Management Office (PMO) for FX Alliance, a global foreign exchange platform, where he was responsible for
enabling project and risk management functions for NewYork, London andTokyo locations. Harpreet earned a Master's
anda Ph.D.degreesfromHarvardUniversity,wherehecurrentlyservesasa facultymember.
THORToumiquet - http://www.thortourniquet.com
AntonHunt,Co-founder,Student- Dept.ofMechanicalEngineeringMIT- antonh@mitedu) 857-600-7943
Antonhasexperienceworkinginandmanagingteamsfroma rangeofdisciplines;jangingj&omtheoilandgas^industryto
thirdworlddevelopmentprogramsto cleanenergyresearchin pursuitofhisPh.D. atMIT. He isdrivento findsimple,
elegant mechanical solutions to everyday problems in thesefields andbeyond! He graduated from Oxford University with
a Masters in engineering science before making hiswayacross the pond to MIT.
Nick Demas. Co-founder - demas@mit. edu
Nickbringsessperience inworkingwith andleadingmedicaldeviceprojects, startups andsmall businesses. Hehasworked
on healthcaretechnologies from cardiovascular pi-ostheses to non-invasive disposable products on technical, clinical
validation,andregulatorychallenges.Heispassionateaboutreducingcostsandimprovingclinicaloutcomesbydeveloping
technologiesfrom'ideastofinalproducts.Nicls_graduatedfromYaleUniversitywitha B.S.inMechanicalEngineeringanc
is currently pursuing his S.M. in Mechanical Engineering at MIT.
Trend Undheim, Ph.D.
http://startupexchange.mit.edu